---
title: "Rapid Micro Biosystems, Inc. (RPID.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RPID.US.md"
symbol: "RPID.US"
name: "Rapid Micro Biosystems, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T12:02:12.504Z"
locales:
  - [en](https://longbridge.com/en/quote/RPID.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RPID.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RPID.US.md)
---

# Rapid Micro Biosystems, Inc. (RPID.US)

## Company Overview

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.rapidmicrobio.com](https://www.rapidmicrobio.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: D (0.63)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 53 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.99% |  |
| Net Profit YoY | -11.83% |  |
| P/B Ratio | 4.44 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 90618739.20 |  |
| Revenue | 34384000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -116.74% | E |
| Profit Margin | -145.81% | E |
| Gross Margin | 4.64% | E |
| Revenue YoY | 15.99% | B |
| Net Profit YoY | -11.83% | D |
| Total Assets YoY | -27.00% | E |
| Net Assets YoY | -68.85% | E |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | 15.99% | B |
| Turnover | 0.47 | C |
| Gearing Ratio | 67.29% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Rapid Micro Biosystems, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.99%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-11.83%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.44",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "90618739.20",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "34384000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-116.74%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-145.81%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "4.64%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "15.99%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-11.83%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-27.00%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-68.85%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "15.99%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.47",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "67.29%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.81 | 32/59 | - | - | - |
| PB | 4.44 | 40/59 | 3.99 | 2.98 | 2.28 |
| PS (TTM) | 2.64 | 20/59 | 5.76 | 4.84 | 3.66 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T04:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.98 |
| Highest Target | 8.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/RPID.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/RPID.US/norm.md)
- [Related News](https://longbridge.com/en/quote/RPID.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/RPID.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**